LifeTech Scientific's (HKG:1302) trustee agreed to acquire 230 million shares from substantial shareholder Xianjian Advanced Technology for HK$437 million or HK$1.90 apiece, a Tuesday Hong Kong bourse filing said.
Shares of the medical device manufacturer were down over 9% in Wednesday afternoon trading.
The shares will be purchased using funding to be provided by the firm for the share award scheme.
The seller, currently holding a 14.99% stake in LifeTech Scientific, will own 464.2 million, or 10.02%, of the latter's issued shares on completion, which is expected Dec. 12.
Xianjian Advanced Technology is wholly owned by Xie Yuehui, LifeTech Scientific's chairman and CEO.
Comments